Global Patent Index - EP 1335717 A4

EP 1335717 A4 20040630 - TREATMENT OF PCP ADDICTION AND PCP ADDICTION-RELATED BEHAVIOR

Title (en)

TREATMENT OF PCP ADDICTION AND PCP ADDICTION-RELATED BEHAVIOR

Title (de)

BEHANDLUNG VON PCP-ABHÄNGIGKEIT UND VERHALTEN IM ZUSAMMENHANG MIT PCP-ABHÄNGIGKEIT

Title (fr)

TRAITEMENT DE LA DEPENDANCE A LA PHENCYCLIDINE (PCP) ET DU COMPORTEMENT ASSOCIE A CETTE DEPENDANCE

Publication

EP 1335717 A4 20040630 (EN)

Application

EP 01913336 A 20010307

Priority

  • US 0107233 W 20010307
  • US 69404000 A 20001023

Abstract (en)

[origin: WO0234249A1] The present invention provides a method for changing addiction-related behavior of a mammal suffering from addiction to hallucinogenic drugs, preferably phencyclidine (PCP). The method includes administering to the mammal an effective amount of gamma vinylGABA (GVG) or a pharmaceutically acceptable salt thereof, or an enantiomer or a racemic mixture thereof, wherein the effective amount is sufficient to diminish, inhibit or eliminate behavior associated with craving or use of PCP.

IPC 1-7

A61K 31/135; A61K 31/165; A61K 31/19; A61K 31/195; A61K 31/221; A61K 31/4535; A61K 31/70

IPC 8 full level

A61K 31/135 (2006.01); A61K 31/165 (2006.01); A61K 31/185 (2006.01); A61K 31/19 (2006.01); A61K 31/197 (2006.01); A61K 31/357 (2006.01); A61K 31/4535 (2006.01); A61K 45/00 (2006.01); A61K 51/04 (2006.01); A61P 25/30 (2006.01)

CPC (source: EP KR US)

A61K 31/195 (2013.01 - KR); A61K 31/197 (2013.01 - EP US); A61K 51/0406 (2013.01 - EP US); A61K 51/0446 (2013.01 - EP US); A61P 25/30 (2018.01 - EP); A61P 25/36 (2018.01 - EP)

Citation (search report)

  • [Y] WO 0007583 A2 20000217 - BROOKHAVEN SCIENCE ASS LLC [US], et al
  • [X] MIDGLEY LEONORA P ET AL: "Characterization of phencyclidine-induced effects on neuropeptide Y systems in the rat caudate-putamen", BRAIN RESEARCH, vol. 593, no. 1, 1992, pages 89 - 96, XP002278047, ISSN: 0006-8993
  • [X] MIDGLEY LEONORA P ET AL: "Differential regulation of neuropeptide Y systems in limbic structures of the rat", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 267, no. 2, 1993, pages 707 - 713, XP009028795, ISSN: 0022-3565
  • [XY] YONEZAWA YUJI ET AL: "Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 341, no. 1, 2 January 1998 (1998-01-02), pages 45 - 56, XP001180623, ISSN: 0014-2999
  • [Y] DEWEY S L ET AL: "GABAERGIC ATTENUATION OF COCAINE-INDUCED DOPAMINE RELEASE AND LOCOMOTOR ACTIVITY", SYNAPSE, WILEY AND SONS, CHICHESTER, GB, vol. 25, no. 4, April 1997 (1997-04-01), pages 393 - 398, XP000856597, ISSN: 0887-4476
  • [Y] DEWEY S L ET AL: "A PHARMACOLOGIC STRATEGY FOR THE TREATMENT OF NICOTINE ADDICTION", SYNAPSE, WILEY AND SONS, CHICHESTER, GB, vol. 31, no. 1, January 1999 (1999-01-01), pages 76 - 86, XP000856613, ISSN: 0887-4476
  • See also references of WO 0234249A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 0234249 A1 20020502; AU 2001242011 B2 20051103; AU 2001242011 B8 20060302; AU 4201101 A 20020506; BR 0114898 A 20030812; CA 2426210 A1 20020502; CA 2426210 C 20091222; CN 1234352 C 20060104; CN 1476326 A 20040218; CN 1771929 A 20060517; CZ 20031431 A3 20040616; EP 1335717 A1 20030820; EP 1335717 A4 20040630; HR P20030322 A2 20050228; HU P0301441 A2 20031128; HU P0301441 A3 20110728; IL 155574 A0 20031123; IL 155574 A 20100217; JP 2004512301 A 20040422; KR 20030074610 A 20030919; MX PA03003589 A 20050816; NO 20031814 D0 20030423; NO 20031814 L 20030619; NZ 526072 A 20040827; PL 361028 A1 20040920; US 6395783 B1 20020528

DOCDB simple family (application)

US 0107233 W 20010307; AU 2001242011 A 20010307; AU 4201101 A 20010301; BR 0114898 A 20010307; CA 2426210 A 20010307; CN 01819228 A 20010307; CN 200510123267 A 20010307; CZ 20031431 A 20010307; EP 01913336 A 20010307; HR P20030322 A 20030423; HU P0301441 A 20010307; IL 15557401 A 20010307; IL 15557403 A 20030424; JP 2002537303 A 20010307; KR 20037005616 A 20030423; MX PA03003589 A 20010307; NO 20031814 A 20030423; NZ 52607201 A 20010307; PL 36102801 A 20010307; US 69404000 A 20001023